[ad_1] Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the nervous system, has published an article on the transplantation of NSI-532.IGF1 in the scientific journal …
Read More »
[ad_1] Germain Town, Maryland – (와이어) October 26, 2018 – Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company specializing in the development of new drugs for the treatment of the nervous system, Related …
Read More »
[ad_1] The Japanese Ministry of Health, Labor and Welfare approved the world's first clinical trial of Parkinson's disease using induced pluripotent stem cells (IPS). IPS cells are stem cells that inject specific …
Read More »
[ad_1] Contrast with Korea, which took a stand on bioethics Japan is pacing in the field of regenerative medicine. Approved a clinical trial of Parkinson's disease using inducible pluripotent stem cells (iPS …
Read More »
[ad_1] The Japanese government approved the Kyoto University project to request a clinical trial of Parkinson's disease using allogeneic stem cells (iPS), the Nikkei newspaper reported on June 30. According to the …
Read More »
[ad_1] Prof. Song Ji-hwan of the Department of Biological Sciences, Daehan University of Science, produced Induced Pluripotent Stem Cells (iPSCs), which could theoretically be transplanted in 41.7% of Koreans without immune rejection …
Read More »
[ad_1] [지구를 보다] Remains the coming Mars, a beautiful rod of light Naew News Mars approach, lunar eclipse, look at Gwacheon Science Museum ZD net Korea 'March' Complete coverage The lunar eclipse …
Read More »